Super™ Llama Anti-A. baumannii Single Domain Antibody-snGFP (WJ155)(Cat#: MDWJ1820)

This product is a Llama single domain antibody recognizes A. baumannii conjugated to snGFP. This product has the ability for cell penetration.
Target A. baumannii
Immunogen Acinetobacter baumannii
Species Reactivity A. baumannii
Application IHC, FC, FuncS, Cell Penetration
Clone WJ155
Host Animal Llama
Isotype sdAb
Clonality Monoclonal
Class Primary
Concentration 1 mg/mL
Conjugation snGFP
Storage Condition Store at 4°C for short term (1-2 weeks). Aliquot and store at -20°C for long term. Avoid repeated freeze/thaw cycles.
Target Background Acinetobacter baumannii is a typically short, almost round, rod-shaped (coccobacillus) Gram-negative bacterium. It can be an opportunistic pathogen in humans, affecting people with compromised immune systems, and is becoming increasingly important as a hospital-derived (nosocomial) infection. It has also been isolated from environmental soil and water samples. Bacteria of this genus lack flagella, whip-like structures many bacteria use for locomotion, but exhibit twitching or swarming motility. This may be due to the activity of type IV pili, pole-like structures that can be extended and retracted. Motility in A. baumannii may also be due to the excretion of exopolysaccharide, creating a film of high-molecular-weight sugar chains behind the bacterium to move forward. Clinical microbiologists typically differentiate members of the Acinetobacter genus from other Moraxellaceae by performing an oxidase test, as Acinetobacter spp. are the only members of the Moraxellaceae to lack cytochrome c oxidases. A. baumannii is part of the ACB complex (A. baumannii, A. calcoaceticus, and Acinetobacter genomic species 13TU). Members of the ACB complex are difficult to determine the specific species, and comprise the most clinically relevant members of the genus. A. baumannii has also been identified as an ESKAPE pathogen (Enterococcus faecalis, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species), a group of pathogens with a high rate of antibiotic resistance that are responsible for the a majority of nosocomial infections. Colloquially, A. baumannii is referred to as 'Iraqibacter' due to its seemingly sudden emergence in military treatment facilities during the Iraq War. It has continued to be an issue for veterans and soldiers who served in Iraq and Afghanistan. Multidrug-resistant A. baumannii has spread to civilian hospitals in part due to the transport of infected soldiers through multiple medical facilities.
Target Synonym A. baumannii; Acinetobacter baumannii; coccobacillus
See other products for " A. baumannii "
KINDLY NOTE
  • Some properties of custom products can be tailored flexibly. Please feel free to send your specific demands through an inquiry.
  • All listed customized sdAb products are for lab research use only, not intended for pharmaceutical, diagnostic, therapeutic or any in vivo human use. For commercial purpose, please review our one-stop solutions for de novo sdAb discovery.
  • No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
  • NCBI/UniProt data is used to refer general target information. It may not necessarily be applicable to one specific product.
  • Creative Biolabs has made every effort to ensure the accuracy of the datasheet and reserves the right to make changes to the datasheet at any time without prior notice. Creative Biolabs will not be liable for any omissions or errors contained herein, please use the COA of your custom products as standard.

If you can't find your product on this list? Please directly send email to

For Research Use Only. Not for diagnostic or therapeutic applications.

Online Inquiry
Interested in our expertise?

Contact us for more information

Get free consultations
USA
  • Tel:
  • Fax:
  • Email:
UK
  • Tel:
  • Email:
Germany
  • Tel:
  • Email:

Enter your email here to subscribe.

Submit

Follow us on

Copyright © 2024 Creative Biolabs. All Rights Reserved.